AVIPRO SALMONELLA DUO
국가: 프랑스
언어: 영어
출처: HMA (Heads of Medicines Agencies)
환자 정보 전단 유효 성분:
salmonella enteritidis 100000000 IU, salmonella typhimurium 100000000 IU
제공처:
Lohmann Animal Health & Co.
ATC 코드:
QI01AE01
약제 형태:
Oral lyophilisate
치료 그룹:
Salmonella
치료 영역:
Chicken Food
승인 날짜:
2011-05-18
환자 정보 전단
1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
AviPro SALMONELLA DUO
Lyophilisate for suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose contains:
ACTIVE SUBSTANCES:
Live attenuated _Salmonella _Enteritidis bacteria, strain Sm24/Rif12/Ssq, min. 1 x 10
8
CFU* and
max. 6 x 10
8
CFU*
Live attenuated _Salmonella _Typhimurium bacteria, strain Nal2/Rif9/Rtt, min. 1 x 10
8
CFU*
and max. 6 x 10
8
CFU*
*CFU = Colony Forming Units
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate for suspension.
Appearance: White gray to white brown pellet.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Chickens (future breeders and layers) and ducks (fattening).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CHICKENS (FUTURE BREEDERS AND LAYERS):
For active immunisation of healthy and susceptible chickens to reduce faecal excretion and colonisation
of internal organs with _Salmonella _Enteritidis and _Salmonella _Typhimurium field strains and to reduce
colonisation of eggs with _Salmonella _Enteritidis field strains.
Onset of immunity: 15 days
Duration of immunity: Duration of immunity for at least 68 weeks of life was shown against virulent _S_.
Enteritidis and for at least 62 weeks of life against virulent _S_. Typhimurium.
DUCKS (FATTENING):
For active immunisation of healthy and susceptible ducks to reduce the colonisation of internal organs
with _Salmonella _Typhimurium field strains.
Onset of immunity: 22 days
Duration of immunity: 43 days
3
4.
전체 문서 읽기
제품 특성 요약
1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
AviPro SALMONELLA DUO
Lyophilisate for suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose contains:
ACTIVE SUBSTANCES:
Live attenuated _Salmonella _Enteritidis bacteria, strain Sm24/Rif12/Ssq, min. 1 x 10
8
CFU* and
max. 6 x 10
8
CFU*
Live attenuated _Salmonella _Typhimurium bacteria, strain Nal2/Rif9/Rtt, min. 1 x 10
8
CFU*
and max. 6 x 10
8
CFU*
*CFU = Colony Forming Units
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate for suspension.
Appearance: White gray to white brown pellet.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Chickens (future breeders and layers) and ducks (fattening).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CHICKENS (FUTURE BREEDERS AND LAYERS):
For active immunisation of healthy and susceptible chickens to reduce faecal excretion and colonisation
of internal organs with _Salmonella _Enteritidis and _Salmonella _Typhimurium field strains and to reduce
colonisation of eggs with _Salmonella _Enteritidis field strains.
Onset of immunity: 15 days
Duration of immunity: Duration of immunity for at least 68 weeks of life was shown against virulent _S_.
Enteritidis and for at least 62 weeks of life against virulent _S_. Typhimurium.
DUCKS (FATTENING):
For active immunisation of healthy and susceptible ducks to reduce the colonisation of internal organs
with _Salmonella _Typhimurium field strains.
Onset of immunity: 22 days
Duration of immunity: 43 days
3
4.
전체 문서 읽기
